Extramedullary solitary plasmacytoma: Demonstrating the role of 18F-FDG PET imaging

Archana Gautam, Kamal Kant Sahu, Ahsan Alamgir, Imran Siddiqi, Sikander Ailawadhi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5% of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.

Original languageEnglish (US)
Pages (from-to)XD01-XD03
JournalJournal of Clinical and Diagnostic Research
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Plasmacytoma
Fluorodeoxyglucose F18
Plasmas
Imaging techniques
Plasma Cells
Positron emission tomography
Positron-Emission Tomography
Plasma Cell Neoplasms
Guidelines
Multiple Myeloma
Monitoring
Costs
Costs and Cost Analysis

Keywords

  • Lambda restriction
  • Multiple Myeloma
  • Surveillance

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry

Cite this

Extramedullary solitary plasmacytoma : Demonstrating the role of 18F-FDG PET imaging. / Gautam, Archana; Sahu, Kamal Kant; Alamgir, Ahsan; Siddiqi, Imran; Ailawadhi, Sikander.

In: Journal of Clinical and Diagnostic Research, Vol. 11, No. 4, 01.04.2017, p. XD01-XD03.

Research output: Contribution to journalArticle

Gautam, Archana ; Sahu, Kamal Kant ; Alamgir, Ahsan ; Siddiqi, Imran ; Ailawadhi, Sikander. / Extramedullary solitary plasmacytoma : Demonstrating the role of 18F-FDG PET imaging. In: Journal of Clinical and Diagnostic Research. 2017 ; Vol. 11, No. 4. pp. XD01-XD03.
@article{785fb553d1994fe9868cc8ee6922a670,
title = "Extramedullary solitary plasmacytoma: Demonstrating the role of 18F-FDG PET imaging",
abstract = "An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5{\%} of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.",
keywords = "Lambda restriction, Multiple Myeloma, Surveillance",
author = "Archana Gautam and Sahu, {Kamal Kant} and Ahsan Alamgir and Imran Siddiqi and Sikander Ailawadhi",
year = "2017",
month = "4",
day = "1",
doi = "10.7860/JCDR/2017/22801.9557",
language = "English (US)",
volume = "11",
pages = "XD01--XD03",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "JCDR Research and Publications (Pvt) Limited",
number = "4",

}

TY - JOUR

T1 - Extramedullary solitary plasmacytoma

T2 - Demonstrating the role of 18F-FDG PET imaging

AU - Gautam, Archana

AU - Sahu, Kamal Kant

AU - Alamgir, Ahsan

AU - Siddiqi, Imran

AU - Ailawadhi, Sikander

PY - 2017/4/1

Y1 - 2017/4/1

N2 - An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5% of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.

AB - An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5% of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.

KW - Lambda restriction

KW - Multiple Myeloma

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=85017027277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017027277&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2017/22801.9557

DO - 10.7860/JCDR/2017/22801.9557

M3 - Article

AN - SCOPUS:85017027277

VL - 11

SP - XD01-XD03

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 4

ER -